Mcgill University

Montreal, Quebec QC H4A 3J1

8 studies enrolling now · 117 studies all time

What they study most

Acute Gastrointestinal Bleeding, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Anemia, Anorexia, Antibody-mediated Rejection, Atrial Fibrillation, B-cell Chronic Lymphocytic Leukemia, Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer

Studies at this site

• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort — Recruiting now
• A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis — Recruiting now
• A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer — Recruiting now
• Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding — Recruiting now
• A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia — Recruiting now
• A Study of Lorigerlimab in Participants With Advanced Solid Tumors — Recruiting now
• Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV) — Recruiting now
• American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry — Recruiting now
• Cryoablation for Monomorphic Ventricular Tachycardia — Running, not enrolling
• Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers — Completed
• A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients — Running, not enrolling
• A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) — Running, not enrolling
• A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes — Completed
• LOWER: Lomitapide Observational Worldwide Evaluation Registry — Completed
• A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease — Stopped early
• A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa) — Completed
• SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma — Running, not enrolling
• Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary Dyskinesia — Completed
• Clear Aligners for the Treatment of Dental Malocclusion in OI — Running, not enrolling
• AMP SCZ® Observational Study: PREDICT-DPACC — Running, not enrolling
• Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease — Running, not enrolling
• Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults — Completed
• Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies — Completed
• A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA) — Running, not enrolling
• A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) — Completed
• North American Prodromal Synucleinopathy Consortium — Enrolling by invitation
• Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. — Completed
• Phase 3 Study to Treat Patients With Soft Tissue Sarcomas — Completed
• Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer — Completed
• Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine — Completed
• A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Stopped early
• Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial — Completed
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia — Completed
• Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma — Completed
• Selinexor in Advanced Liposarcoma — Completed
• Genetics of Primary Ciliary Dyskinesia — Completed
• Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy — Completed
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer — Completed
• Phase 3 Extension Study of Dexpramipexole in ALS — Stopped early
• Narcotic vs. Non-narcotic Pain Study Protocol — Completed
• Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma — Completed
• A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy — Completed
• Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases — Completed
• Phase 3 Study of Dexpramipexole in ALS — Completed
• Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash — Completed
• Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer — Completed
• Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases — Completed
• Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer — Completed
• Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme — Completed
• Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme — Completed